Robert D. Timmerman

Robert D. Timmerman's AcademicInfluence.com Rankings

Robert D. Timmerman

Medical

#2407

World Rank

#2830

Historical Rank

Oncology

#145

World Rank

#150

Historical Rank

Surgery

#194

World Rank

#242

Historical Rank

medical Degrees

Robert D. Timmerman

Philosophy

#7002

World Rank

#10142

Historical Rank

Logic

#4082

World Rank

#5329

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Why Is Robert D. Timmerman Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Robert D. Timmerman's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Stereotactic body radiation therapy for inoperable early stage lung cancer. (2010) (2246)
Stereotactic body radiation therapy: the report of AAPM Task Group 101. (2010) (1545)
Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. (2006) (1101)
Radiation dose-volume effects in the lung. (2010) (890)
Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study. (2009) (772)
Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer. (2003) (671)
Consolidative Radiotherapy for Limited Metastatic Non–Small-Cell Lung Cancer: A Phase 2 Randomized Clinical Trial (2018) (610)
Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy. (2008) (584)
American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy. (2004) (511)
Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial. (2017) (477)
Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study. (2005) (475)
Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases. (2003) (438)
An overview of hypofractionation and introduction to this issue of seminars in radiation oncology. (2008) (422)
Stereotactic body radiation therapy in multiple organ sites. (2007) (401)
A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases. (2005) (383)
Stereotactic body radiation therapy: a novel treatment modality (2010) (340)
Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based Guideline. (2017) (310)
Consideration of dose limits for organs at risk of thoracic radiotherapy: atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs, and brachial plexus. (2011) (293)
A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer: NRG Oncology RTOG 0915 (NCCTG N0927). (2015) (261)
Occult central nervous system involvement in patients with metastatic breast cancer: prevalence, predictive factors and impact on overall survival. (2003) (237)
Phase II trial of stereotactic body radiation therapy combined with erlotinib for patients with limited but progressive metastatic non-small-cell lung cancer. (2014) (236)
Observation-only management of early stage, medically inoperable lung cancer: poor outcome. (2002) (228)
Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non-Small-Cell Lung Cancer: NRG Oncology/RTOG 0813 Trial. (2019) (225)
Stereotactic Body Radiation Therapy: A Comprehensive Review (2007) (222)
Stereotactic Body Radiation Therapy for Operable Early-Stage Lung Cancer: Findings From the NRG Oncology RTOG 0618 Trial (2018) (203)
An Eight-year Follow-up to a Randomized Clinical Trial of Participant Satisfaction with Three Types of Mandibular Implant-retained Overdentures (2004) (200)
Phase I dose-escalation study of stereotactic body radiation therapy for low- and intermediate-risk prostate cancer. (2011) (197)
Phase I Dose-Escalation Study of Stereotactic Body Radiotherapy in Patients With Hepatic Metastases (2011) (192)
Interim analysis of a prospective phase I/II trial of SBRT for liver metastases (2006) (191)
Emergence of stereotactic body radiation therapy and its impact on current and future clinical practice. (2014) (189)
Long-term Results of RTOG 0236: A Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Patients with Medically Inoperable Stage I Non-Small Cell Lung Cancer (2014) (188)
Four-dimensional computed tomography scan analysis of tumor and organ motion at varying levels of abdominal compression during stereotactic treatment of lung and liver. (2008) (182)
Predictors of rectal tolerance observed in a dose-escalated phase 1-2 trial of stereotactic body radiation therapy for prostate cancer. (2014) (180)
Local Surgical, Ablative, and Radiation Treatment of Metastases (2009) (179)
Stereotactic body radiation therapy. (2004) (177)
RTOG 0631 phase 2/3 study of image guided stereotactic radiosurgery for localized (1-3) spine metastases: phase 2 results. (2014) (173)
Dosimetric evaluation of heterogeneity corrections for RTOG 0236: stereotactic body radiotherapy of inoperable stage I-II non-small-cell lung cancer. (2007) (163)
Brachial plexopathy from stereotactic body radiotherapy in early-stage NSCLC: dose-limiting toxicity in apical tumor sites. (2009) (154)
The Confluence of Stereotactic Ablative Radiotherapy and Tumor Immunology (2011) (151)
Long-term Follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer. (2017) (149)
The North American Experience with Stereotactic Body Radiation Therapy in Non-small Cell Lung Cancer (2007) (144)
Multicenter phase Ib/II trial of the radiation enhancer motexafin gadolinium in patients with brain metastases. (2001) (142)
Treatment of stage I lung cancer in high-risk and inoperable patients: comparison of prospective clinical trials using stereotactic body radiotherapy (RTOG 0236), sublobar resection (ACOSOG Z4032), and radiofrequency ablation (ACOSOG Z4033). (2013) (141)
Neutrophil–Lymphocyte and Platelet–Lymphocyte Ratios as Prognostic Factors after Stereotactic Radiation Therapy for Early-Stage Non–Small-Cell Lung Cancer (2015) (139)
No clinically significant changes in pulmonary function following stereotactic body radiation therapy for early- stage peripheral non-small cell lung cancer: an analysis of RTOG 0236. (2014) (137)
American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guidelines for image-guided radiation therapy (IGRT). (2010) (136)
American Society for Therapeutic Radiology and Oncology and American College of Radiology practice guideline for the performance of stereotactic body radiation therapy. (2004) (132)
Extracranial radiosurgery (stereotactic body radiation therapy) for oligometastases. (2006) (132)
A deep convolutional neural network-based automatic delineation strategy for multiple brain metastases stereotactic radiosurgery (2017) (122)
Accreditation and quality assurance for Radiation Therapy Oncology Group: Multicenter clinical trials using Stereotactic Body Radiation Therapy in lung cancer (2006) (119)
A pilot trial of serial 18F-fluorodeoxyglucose positron emission tomography in patients with medically inoperable stage I non-small-cell lung cancer treated with hypofractionated stereotactic body radiotherapy. (2010) (117)
Long-term Results of Stereotactic Body Radiation Therapy in Medically Inoperable Stage I Non–Small Cell Lung Cancer (2018) (113)
The role of local therapy in the management of lung and liver oligometastases (2011) (111)
FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer (2007) (107)
Stereotactic body radiation therapy for low and intermediate risk prostate cancer-Results from a multi-institutional clinical trial. (2016) (103)
Isolated central nervous system progression on Crizotinib (2012) (97)
Radiation DoseVolume Effects in the Lung (2010) (96)
Stereotactic body radiation therapy for oligometastases (2009) (94)
FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer. (2005) (91)
Baseline pulmonary function as a predictor for survival and decline in pulmonary function over time in patients undergoing stereotactic body radiotherapy for the treatment of stage I non-small-cell lung cancer. (2008) (90)
RTOG 0618: Stereotactic body radiation therapy (SBRT) to treat operable early-stage lung cancer patients. (2013) (89)
American College of Surgeons Oncology Group Z4099/Radiation Therapy Oncology Group 1021: a randomized study of sublobar resection compared with stereotactic body radiotherapy for high-risk stage I non-small cell lung cancer. (2012) (87)
Extracranial Stereotactic Radioablation Physical Principles (2003) (87)
Primary Study Endpoint Analysis for NRG Oncology/RTOG 0813 Trial of Stereotactic Body Radiation Therapy (SBRT) for Centrally Located Non-Small Cell Lung Cancer (NSCLC) (2016) (83)
Stereotactic radiotherapy of primary lung cancer and other targets: results of consultant meeting of the International Atomic Energy Agency. (2011) (79)
Treating tumors that move with respiration (2007) (79)
Cost-effectiveness analysis of stereotactic body radiation therapy versus intensity-modulated radiation therapy: an emerging initial radiation treatment option for organ-confined prostate cancer. (2012) (77)
MRI-only brain radiotherapy: Assessing the dosimetric accuracy of synthetic CT images generated using a deep learning approach. (2019) (76)
RTOG 0631 Phase II/III Study of Image-Guided Stereotactic Radiosurgery for Localized (1-3) Spine Metastases: Phase II Results. (2011) (75)
The Metastatic Spine Disease Multidisciplinary Working Group Algorithms. (2015) (74)
Serious complications associated with stereotactic ablative radiotherapy and strategies to mitigate the risk. (2013) (71)
Image-Guided and Adaptive Radiation Therapy (2012) (71)
Monte carlo simulation of the Leksell Gamma Knife: II. Effects of heterogeneous versus homogeneous media for stereotactic radiosurgery. (2004) (68)
Efficacy and Toxicity Analysis of NRG Oncology/RTOG 0813 Trial of Stereotactic Body Radiation Therapy (SBRT) for Centrally Located Non-Small Cell Lung Cancer (NSCLC) (2016) (68)
Efficacy of ablative high-dose-per-fraction radiation for implanted human renal cell cancer in a nude mouse model. (2006) (66)
Safety and Efficacy of Stereotactic Ablative Radiation Therapy for Renal Cell Carcinoma Extracranial Metastases. (2017) (64)
Extracranial Stereotactic Radiation Delivery: Expansion of Technology Beyond the Brain (2003) (64)
Redesigning radiotherapy quality assurance: opportunities to develop an efficient, evidence-based system to support clinical trials--report of the National Cancer Institute Work Group on Radiotherapy Quality Assurance. (2012) (64)
Stereotactic ablative body radiosurgery (SABR) or Stereotactic body radiation therapy (SBRT)☆ (2017) (62)
Stereotactic Body Radiation Therapy for Lung Cancer (2008) (58)
Monte Carlo simulation of the Leksell Gamma Knife: I. Source modelling and calculations in homogeneous media. (2002) (58)
Radiosurgery Compared To External Beam Radiotherapy for Localized Spine Metastasis: Phase III Results of NRG Oncology/RTOG 0631 (2019) (56)
Precision Hypofractionated Radiation Therapy in Poor Performing Patients With Non-Small Cell Lung Cancer: Phase 1 Dose Escalation Trial. (2015) (56)
A study on the dosimetric accuracy of treatment planning for stereotactic body radiation therapy of lung cancer using average and maximum intensity projection images. (2010) (55)
Technology for Innovation in Radiation Oncology. (2015) (53)
Extracranial stereotactic radiation delivery. (2005) (52)
Gamma-Knife-Based Stereotactic Radiosurgery for Uveal Melanoma (2007) (52)
A Phase I Dose-Escalation Trial of Single-Fraction Stereotactic Radiation Therapy for Liver Metastases (2015) (51)
Role of interim 18F-FDG-PET/CT for the early prediction of clinical outcomes of Non-Small Cell Lung Cancer (NSCLC) during radiotherapy or chemo-radiotherapy. A systematic review (2017) (50)
Stereotactic ablative radiotherapy: what's in a name? (2011) (49)
Multi-objective radiomics model for predicting distant failure in lung SBRT (2017) (49)
Results of COG ACNS0331: A Phase III Trial of Involved-Field Radiotherapy (IFRT) and Low Dose Craniospinal Irradiation (LD-CSI) with Chemotherapy in Average-Risk Medulloblastoma: A Report from the Children's Oncology Group (2016) (49)
Surgery versus stereotactic body radiation therapy for early-stage lung cancer: who's down for the count? (2010) (49)
How should we describe the radioblologic effect of extracranial stereotactic radlosurgery: equivalent uniform dose or tumor control probability? (2003) (49)
Stereotactic Ablative Radiotherapy (SAbR) Used to Defer Systemic Therapy in Oligometastatic Renal Cell Cancer. (2019) (47)
Dosimetric verification using monte carlo calculations for tissue heterogeneity-corrected conformal treatment plans following RTOG 0813 dosimetric criteria for lung cancer stereotactic body radiotherapy. (2012) (46)
Optimizing dose and fractionation for stereotactic body radiation therapy. Normal tissue and tumor control effects with large dose per fraction. (2007) (46)
A dosimetric comparison of stereotactic body radiation therapy techniques for lung cancer: robotic versus conventional linac‐based systems (2010) (46)
Shell feature: a new radiomics descriptor for predicting distant failure after radiotherapy in non-small cell lung cancer and cervix cancer (2017) (46)
Use of the Leksell Gamma Knife for Localized Small Field Lens Irradiation in Rodents (2003) (45)
Frame-based immobilization and targeting for stereotactic body radiation therapy. (2007) (45)
Predicting distant failure in early stage NSCLC treated with SBRT using clinical parameters. (2016) (45)
Rationale of technical requirements for NRG-BR001: The first NCI-sponsored trial of SBRT for the treatment of multiple metastases. (2016) (43)
A Phase II Trial of Stereotactic Ablative Radiotherapy as a Boost for Locally Advanced Cervical Cancer. (2019) (42)
Preliminary Results of a Phase 1 Dose-Escalation Trial for Early-Stage Breast Cancer Using 5-Fraction Stereotactic Body Radiation Therapy for Partial-Breast Irradiation. (2017) (42)
Stereotactic ablative radiotherapy for non-small cell lung cancer: rationale and outcomes. (2012) (42)
A pilot study of preirradiation chemotherapy and 1800 cGy craniospinal irradiation in young children with medulloblastoma. (2004) (41)
Stereotactic Body Radiation Therapy for Prostate Cancer: Review of Experience of a Multicenter Phase I/II Dose-Escalation Study (2014) (41)
Stereotactic radiosurgery and stereotactic body radiation therapy: an overview of technical considerations and clinical applications. (2006) (40)
Endocrine Response after Gamma Knife-Based Stereotactic Radiosurgery for Secretory Pituitary Adenoma (2008) (40)
Phosphorus-32 therapy for cystic craniopharyngiomas. (2011) (39)
Optimal imaging surveillance after stereotactic ablative radiation therapy for early-stage non-small cell lung cancer: Findings of an International Delphi Consensus Study. (2018) (37)
Comparison of 3-D Conformal and Intensity Modulated Radiation Therapy Outcomes for Locally Advanced Non-Small Cell Lung Cancer in NRG Oncology/RTOG 0617 (2015) (36)
Stereotactic Ablative Radiation Therapy for Primary Lung Tumors (2011) (35)
Hypofractionation in radiation therapy and its impact. (2007) (35)
Stereotactic Body Radiation Therapy for Medically Inoperable Early-stage Lung Cancer Patients: Analysis of RTOG 0236 (2009) (35)
The role of Gamma Knife Radiosurgery in the management of unresectable gross disease or gross residual disease after surgery in ependymoma (2006) (35)
Biological-based optimization and volumetric modulated arc therapy delivery for stereotactic body radiation therapy. (2011) (34)
Stereotactic Radiosurgery and Fractionated Stereotactic Radiotherapy in the Treatment of Uveal Melanoma (2006) (34)
An Orthotopic Lung Tumor Model for Image-Guided Microirradiation in Rats (2010) (34)
Stereotactic body radiation therapy for early-stage non-small-cell lung cancer (2008) (32)
Ablation of a site of progression with stereotactic body radiation therapy extends sunitinib treatment from 14 to 22 months. (2013) (32)
Effect of Estrogen on Radiation-Induced Cataractogenesis (2006) (32)
Toxicity Analysis of RTOG 0236 Using Stereotactic Body Radiation Therapy to Treat Medically Inoperable Early Stage Lung Cancer Patients (2007) (31)
Safety and efficacy of concurrent immune checkpoint inhibitors and hypofractionated body radiotherapy (2018) (31)
Brachytherapy for the prevention of stenosis in a canine hemodialysis graft model: preliminary observations. (1999) (31)
The Impact of Mid-Treatment MRI on Defining Boost Volumes in the Radiation Treatment of Glioblastoma Multiforme (2004) (31)
Stereotactic Ablative Radiotherapy Uncertainties: Delineation, Setup and Motion. (2018) (31)
Efficacy of high dose per fraction radiation for implanted human prostate cancer in a nude mouse model. (2006) (30)
Localization accuracy and immobilization effectiveness of a stereotactic body frame for a variety of treatment sites. (2013) (29)
Gamma Knife Stereotactic Radiosurgery for Low-Grade Astrocytomas (2009) (29)
A phase I trial of temozolomide and lomustine in newly diagnosed high-grade gliomas of childhood. (2008) (29)
Stereotactic Ablative Radiotherapy (SABR) for Non–Small Cell Lung Cancer (2013) (29)
Stereotactic body radiation therapy (stereotactic ablative radiotherapy) for stage I non-small cell lung cancer--updates of radiobiology, techniques, and clinical outcomes. (2010) (29)
Dosimetric evaluation of synthetic CT generated with GANs for MRI‐only proton therapy treatment planning of brain tumors (2020) (28)
Stereotactic Body Radiation Therapy for Inoperable Lung Cancer—Reply (2010) (28)
Dosimetric comparison of rectal-sparing capabilities of rectal balloon vs injectable spacer gel in stereotactic body radiation therapy for prostate cancer: lessons learned from prospective trials. (2017) (27)
Stereotactic body radiation therapy for thoracic cancers: recommendations for patient selection, setup and therapy. (2011) (27)
Prolonged survival of a patient with papillary renal cell carcinoma and brain metastases using pazopanib. (2013) (27)
Stereotactic body radiation therapy: a treatment in need of basic biological research. (2006) (26)
Lung cancer: a model for implementing stereotactic body radiation therapy into practice. (2007) (26)
Optic neuropathy and blindness associated with crizotinib for non-small-cell lung cancer with EML4-ALK translocation. (2015) (25)
The Metastatic Spine Disease Multidisciplinary Working Group Algorithms (2019) (25)
A Retrospective Analysis of Tumor Volumetric Responses to Five-Fraction Stereotactic Radiotherapy for Paragangliomas of the Head and Neck (Glomus Tumors) (2014) (25)
Cyberknife stereotactic radiosurgery and radiation therapy treatment planning system. (2018) (24)
Phase 1 Fractional Dose-Escalation Study of Equipotent Stereotactic Radiation Therapy Regimens for Early-Stage Glottic Larynx Cancer. (2019) (24)
Emphasis on Repair, Not Just Avoidance of Injury, Facilitates Prudent Stereotactic Ablative Radiotherapy. (2017) (24)
Two-dimensional film dosimetry application in heterogeneous materials exposed to megavoltage photon beams. (1997) (23)
A Phase III Randomized Study of Image Guided Conventional (60 Gy/30 fx) Versus Accelerated, Hypofractionated (60 Gy/15 fx) Radiation for Poor Performance Status Stage II and III NSCLC Patients—An Interim Analysis (2016) (23)
Neoadjuvant SAbR for Renal Cell Carcinoma Inferior Vena Cava Tumor Thrombus - Safety Lead-in Results of a Phase II Trial. (2021) (23)
Extracranial stereotactic radioablation: results of a phase I study in stage I non-small cell lung cancer (2003) (23)
SBRT for early-stage glottic larynx cancer—Initial clinical outcomes from a phase I clinical trial (2017) (22)
Interim 18F-FDG-PET/CT during chemo-radiotherapy in the management of oesophageal cancer patients. A systematic review. (2017) (22)
Volumetric modulated arc therapy based total body irradiation: Workflow and clinical experience with an indexed rotational immobilization system (2017) (22)
The Role of Hypofractionated Radiation Therapy with Photons, Protons, and Heavy Ions for Treating Extracranial Lesions (2016) (22)
A recursive ensemble organ segmentation (REOS) framework: application in brain radiotherapy (2019) (22)
Stereotactic Radiosurgery for Multiple Brain Metastases From Renal‐Cell Carcinoma (2019) (21)
Imaging Artifacts in Echocardiography (2016) (21)
Stereotactic body radiation therapy for early non-small cell lung cancer. (2010) (21)
Contamination dose from photoneutron processes in bodily tissues during therapeutic radiation delivery. (2003) (21)
Dosimetric and deformation effects of image-guided interventions during stereotactic body radiation therapy of the prostate using an endorectal balloon. (2012) (21)
Preliminary experience in the treatment of choroidal melanoma with gamma knife radiosurgery. (2000) (21)
Accelerated Hypofractionated Image-Guided vs Conventional Radiotherapy for Patients With Stage II/III Non-Small Cell Lung Cancer and Poor Performance Status: A Randomized Clinical Trial. (2021) (21)
4D DMLC leaf sequencing to minimize organ at risk dose in moving anatomy. (2007) (20)
Stereotactic body radiation therapy. (2005) (20)
Stereotactic radiation therapy of renal cancer inferior vena cava tumor thrombus (2015) (20)
A Phase II Study with Cetuximab and Radiation Therapy for Patients with Surgically Resectable Esophageal and GE Junction Carcinomas: Hoosier Oncology Group G05-92 (2013) (19)
Dosimetric and motion analysis of margin-intensive therapy by stereotactic ablative radiotherapy for resectable pancreatic cancer (2011) (19)
Raccoon Eyes and Neuroblastoma (2003) (19)
A Phase 2 Clinical Trial of SABR Followed by Immediate Vertebroplasty for Spine Metastases. (2019) (19)
Role of stereotactic radiosurgery and fractionated stereotactic radiotherapy in pediatric brain tumors (2008) (19)
Automatic metastatic brain tumor segmentation for stereotactic radiosurgery applications (2016) (19)
Optimization of normalized prescription isodose selection for stereotactic body radiation therapy: conventional vs robotic linac. (2013) (18)
Improved Survival Outcomes for Kidney Cancer Patients With Brain Metastases (2019) (18)
Stereotactic ablative body radiotherapy (SAbR) for oligometastatic cancer. (2017) (18)
Stereotactic body radiation therapy (SBRT) for genitourinary malignancies. (2010) (18)
Stereotactic ablative body radiation therapy for tumors in the lung in octogenarians: a retrospective single institution study (2014) (18)
Neoadjuvant Stereotactic Radiosurgery Before Surgical Resection of Cerebral Metastases. (2018) (17)
Imaging changes after stereotactic body radiation therapy for lung and liver tumors (2011) (17)
Wound Complications Associated With Brachytherapy for Primary or Salvage Treatment of Head and Neck Cancer (1997) (17)
Early and multiple PSA bounces can occur following high-dose prostate stereotactic body radiation therapy: Subset analysis of a phase 1/2 trial. (2017) (17)
Hypofractionated External-Beam Radiotherapy for Prostate Cancer (2013) (17)
Initial Report of a Prospective Phase II Trial of Stereotactic Body Radiation Therapy for Patients with Medically Inoperable Stage I Non-small Cell Lung Cancer (2005) (17)
Safety and feasibility of motexafin gadolinium administration with whole brain radiation therapy and stereotactic radiosurgery boost in the treatment of ≤6 brain metastases: a multi-institutional phase II trial (2011) (17)
Inverse 4D conformal planning for lung SBRT using particle swarm optimization (2016) (16)
Stereotactic Body Radiation Therapy for Early-Stage Lung Cancer. (2016) (15)
Stereotactic body radiation therapy: normal tissue and tumor control effects with large dose per fraction. (2011) (15)
Cost-effectiveness analysis of SBRT versus IMRT: an emerging initial radiation treatment option for organ-confined prostate cancer. (2012) (15)
New Techniques for Irradiating Early Stage Breast Cancer: Stereotactic Partial Breast Irradiation. (2017) (15)
Multi-staged robotic stereotactic radiosurgery for large cerebral arteriovenous malformations. (2013) (15)
A pilot study using kernelled support tensor machine for distant failure prediction in lung SBRT (2018) (15)
Consolidative Radiotherapy for Limited Metastatic Non–Small Cell Lung Cancer: A Randomized Phase 2 Trial (2017) (14)
Review of treatment options for oligometastatic non-small cell lung cancer. (2015) (14)
The expanding roles of stereotactic body radiation therapy and oligofractionation: toward a new practice of radiotherapy. (2011) (14)
Phase II Trial of Hippocampal-Sparing Whole Brain Irradiation with Simultaneous Integrated Boost (HSIB-WBRT) for Metastatic Cancer. (2020) (14)
Dosimetric comparison of Acuros XB with collapsed cone convolution/superposition and anisotropic analytic algorithm for stereotactic ablative radiotherapy of thoracic spinal metastases (2015) (14)
Personalized Ultra-fractionated Stereotactic Adaptive Radiotherapy (PULSAR) in preclinical models enhances single agent immune checkpoint blockade. (2021) (14)
SABR for aggressive local therapy of metastatic cancer: A new paradigm for metastatic non-small cell lung cancer. (2015) (13)
Which MR imaging sequences are necessary in determining the need for radiation therapy for cord compression? A prospective study. (2007) (13)
Stereotactic body radiation therapy for nonpulmonary primary tumors (2008) (13)
Comparative Dose-Volume Analysis for CyberKnife and 3D Conformal Partial Breast Irradiation Treatment of Early Stage Breast Cancer (2010) (13)
Multi-Institutional Phase 2 Trial of High-Dose Stereotactic Body Radiation Therapy with Temporary Hydrogel Spacer for Low- and Intermediate-Risk Prostate Cancer (2017) (13)
Stereotactic Ablative Radiation Therapy for Oligoprogressive Renal Cell Carcinoma (2021) (13)
Phase II trial of high-dose interleukin-2 (IL-2) and stereotactic radiation therapy (SABR) for metastatic clear cell renal cell carcinoma (ccRCC): Interim analysis. (2016) (12)
Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios as Prognostic Factors Following Stereotactic Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer (2014) (12)
Effective Rat Lung Tumor Model for Stereotactic Body Radiation Therapy (2016) (12)
Adjuvant radiation for stage IIb soft tissue sarcoma of the extremity. (2002) (12)
Phase II Trial of Stereotactic Ablative Radiation for Oligoprogressive Metastatic Kidney Cancer. (2021) (12)
Development of a modified head and neck quality assurance phantom for use in stereotactic radiosurgery trials (2013) (12)
Lung cancer specialists' opinions on treatment for stage I non-small cell lung cancer: A multidisciplinary survey (2018) (11)
Brain metastasis from non-seminomatous germ cell tumor of the testis (2007) (11)
Stereotactic Ablative Radiation Therapy (SAbR) Used to Defer Systemic Therapy in Oligometastatic Renal Cell Cancer (2020) (11)
Stereotactic ablative radiation therapy for renal cell carcinoma with inferior vena cava tumor thrombus. (2022) (11)
Extracranial stereotactic radioablation. Review of biological basis, technique and preliminary clinical experience (2002) (11)
Adrenal insufficiency after stereotactic body radiation therapy for bilateral adrenal metastases. (2015) (11)
Inversed-Planned Respiratory Phase Gating in Lung Conformal Radiation Therapy. (2017) (10)
Virtual Bronchoscopy-Guided Treatment Planning to Map and Mitigate Radiation-Induced Airway Injury in Lung SAbR. (2018) (10)
VA-Radiation Oncology Quality Surveillance Program. (2020) (10)
Application of Critical Volume-Dose Constraints for Stereotactic Body Radiation Therapy in NRG Radiation Therapy Trials. (2017) (10)
A Web-based Brain Metastases Segmentation and Labeling Platform for Stereotactic Radiosurgery. (2020) (10)
In regard to Donaldson et al: results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma-a report from the IRSG. IJROBP 2001;51:718-728. (2002) (10)
In Reply to Dr. Tomé (2008) (10)
Comprar Robotic Radiosurgery. Treating Tumors that Move with Respiration | Urschel, Harold C. | 9783540698852 | Springer (2007) (10)
Comprehensive target geometric errors and margin assessment in stereotactic partial breast irradiation (2017) (10)
Stereotactic body radiation therapy for oligometastases. (2010) (9)
Dosimetric comparison of Acuros XB with collapsed cone convolution/superposition and anisotropic analytic algorithm for stereotactic ablative radiotherapy of thoracic spinal metastases. (2015) (9)
Images in clinical medicine. Raccoon eyes and neuroblastoma. (2003) (9)
Hydrogel Spacer Rectal Wall Infiltration Associated With Severe Rectal Injury and Related Complications After Dose Intensified Prostate Cancer Stereotactic Ablative Radiation Therapy (2021) (9)
The Unifying (Hybrid) Survival Curve and Single Fraction Equivalent Dose: Useful Tools in Understanding the Potency of Ablative Radiation Therapy (2007) (9)
Surface Guided Motion Management in Glottic Larynx Stereotactic Body Radiation Therapy. (2020) (9)
Multistage stereotactic radiosurgery for large cerebral arteriovenous malformations using the Gamma Knife platform (2017) (8)
Brachial Plexopathy (BP) from Stereotactic Body Radiotherapy (SBRT) in Early-Stage NSCLC: Dose-limiting Toxicity in Apical Tumor Sites (2008) (8)
Long-Term Results of a Phase I Dose-Escalation Trial and Subsequent Institutional Experience of Single-Fraction Stereotactic Ablative Radiation Therapy for Liver Metastases. (2020) (8)
45 : A Prospective Trial of Serial FGD-PET in Patients With Medically Inoperable Stage I Non-Small Cell Lung Cancer Treated With Hypofractionated Stereotactic Body Radiotherapy (SBRT) (2006) (8)
Lung Cancer Radiation Therapy: Monte Carlo Investigation of “Under Dose” by High Energy Photons (2004) (8)
Risk factors for fat necrosis after stereotactic partial breast irradiation (S-PBI) for early stage breast cancer in a phase I clinical trial. (2019) (8)
Cosmetic outcomes of a phase I dose escalation study of 5-fraction stereotactic partial breast irradiation for early stage breast cancer. (2021) (8)
Stereotactic body radiation therapy for early stage non-small cell lung cancer (Expert Review of Anticancer Therapy (2008) 8, 1 (87-98)) (2009) (8)
Phase II trial of motexafin gadolinium (MGd, xcytrin®) and cranial radiation in newly diagnosed glioblastoma multiforme (GBM) (2002) (8)
Deep-learning and radiomics ensemble classifier for false positive reduction in brain metastases segmentation (2021) (7)
Predictors of Acute Toxicity after Stereotactic Body Radiation Therapy for Low and Intermediate-risk Prostate Cancer: Secondary Analysis of a Phase I Trial (2011) (7)
Volumetric Modulated Arc Therapy Enabled Total Body Irradiation (VMAT-TBI): Six-year Clinical Experience and Treatment Outcomes. (2021) (7)
Outcome and Immune Correlates of a Phase II Trial of High-Dose Interleukin-2 and Stereotactic Ablative Radiotherapy for Metastatic Renal Cell Carcinoma (2021) (7)
The development of stereotactic body radiotherapy in the past decade: a global perspective. (2015) (7)
Spinal Nerve Tolerance to Single-Session Stereotactic Ablative Radiation Therapy. (2019) (7)
Malignant familial glomus jugulare and contralateral carotid body tumor. (1997) (7)
Long-Term Toxicity of Radiation Therapy (2003) (7)
A Multi-Institutional Phase II Trial of High-Dose SAbR for Prostate Cancer Using Rectal Spacer. (2021) (7)
A radiation oncologist's and thoracic surgeon's view on the role of stereotactic ablative radiotherapy for operable lung cancer. (2013) (7)
Benchmarking techniques for stereotactic body radiotherapy for early-stage glottic laryngeal cancer: LINAC-based non-coplanar VMAT vs. Cyberknife planning (2019) (7)
Radiation therapy of external iliac lymph nodes with lateral pelvic portals: identification of patients at risk for inadequate regional coverage. (1995) (7)
Systematic Review and Meta-Analysis on the Use of Photon-based Stereotactic Radiosurgery Versus Fractionated Stereotactic Radiotherapy for the Treatment of Uveal Melanoma (2020) (6)
Preliminary Results of Multi-Institutional Phase I Dose Escalation Trial Using Single Fraction Stereotactic Partial Breast Irradiation for Early Stage Breast Cancer: Dose Escalated Single Fraction Stereotactic PBI. (2021) (6)
Fundamentals of Radiation Oncology for Neurologic Imaging. (2020) (6)
Intracranial anaplastic hemangiopericytoma presenting with simultaneous extra-cranial metastases: A case report and review of the literature (2019) (6)
Functionally weighted airway sparing (FWAS): a functional avoidance method for preserving post-treatment ventilation in lung radiotherapy (2020) (6)
Gamma Knife Radiosurgery in the Treatment of Choroidal Neovascularization (Wet-Type Macular Degeneration) (2006) (6)
Radiation Therapy for Pediatric Brain Tumors using Robotic Radiation Delivery System and Intensity Modulated Proton Therapy. (2020) (5)
BED CALCULATIONS FOR FRACTIONS OF VERY HIGH DOSE : IN REGARD TO PARK ET AL. (INT J RADIA T ONCOL BIOL PHYS 2007;69:S623-S624). Authors' reply (2008) (5)
Phantom-to-clinic development of hypofractionated stereotactic body radiotherapy for early-stage glottic laryngeal cancer. (2017) (5)
Quantitative Analysis of Three-dimensional Conformal Radiotherapy Techniques for Posterior Fossa Treatment in Children (2003) (5)
Dosimetric and Economic Comparison of Interstitial High-Dose-Rate Brachytherapy to Stereotactic Body Radiation Therapy for Liver Lesions (2015) (5)
In Response to Dr. Astrahan (2008) (5)
Addition of Iodinated Contrast to Rectal Hydrogel Spacer to Facilitate MRI-Independent Target Delineation and Treatment Planning for Prostate Cancer. (2019) (5)
Pulmonary Hilar Stereotactic Body Radiation Therapy in the Rat (2007) (5)
Successful Treatment of a Skull Base Malignant Rhabdoid Tumor with Surgery, Chemotherapy and Gamma Knife-Based Stereotactic Radiosurgery in a Young Child (2007) (5)
In Reply to Drs. McKenna and Ahmad (2009) (5)
Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR) in Preclinical Models Enhances Single-Agent Immune Checkpoint Blockade (2021) (5)
A Randomized, Phase III Study of Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) in High-Risk Patients with Stage I Non-Small Cell Lung Cancer (NSCLC) (2022) (5)
Rib fracture following stereotactic body radiotherapy: a potential pitfall. (2011) (5)
Oculomotor Schwannomas: A Systematic Review and Report of Two Pediatric Cases Treated with Fractionated Cyberknife Stereotactic Radiotherapy. (2019) (5)
The Song/Kavanagh/Benedict et al article reviewed (2004) (5)
Stereotactic Ablative Radiation for Systemic Therapy-naïve Oligometastatic Kidney Cancer. (2022) (5)
In Reply to Dr. Fowler and Dr. Kavanagh (2008) (5)
Expanded Radiosurgery Capabilities Utilizing Gamma Knife Icon™ (2021) (4)
OC-0136: Primary Study Endpoint Analysis of NRG Oncology/RTOG 0813 Trial of SBRT for centrally located NSCLC (2016) (4)
The Quality of Toxicity Reporting and the Story of the Lung SBRT "No-Fly Zone". In Regard to Oskan. (2015) (4)
Stereotactic Ablative Radiotherapy for Oligoprogressive Metastatic Renal Cell Carcinoma (2019) (4)
Prostate Cancer Neurovascular Element Sparing with Stereotactic Ablative Radiation Therapy (SAbR): A Pilot Dosimetric Study for the POTEN-C Trial (2018) (4)
Future Directions in the Use of SAbR for the Treatment of Oligometastatic Cancers. (2021) (4)
LBA28 SAFETY LEAD-IN OF A PHASE II TRIAL OF NEO-ADJUVANT SABR FOR IVC TUMOR THROMBUS IN RCC (2018) (4)
Real-Time Whole-Brain Radiation Therapy: A Single-Institution Experience. (2017) (4)
Erratum to: The Metastatic Spine Disease Multidisciplinary Working Group Algorithms (The Oncologist, (2015), 20, 10, (1205-1215), 10.1634/theoncologist.2015-0085) (2019) (4)
2082 Clinical trial of gadolinium texaphyrin (GD-TEX) in patients with brain metastases (1999) (4)
SU-E-T-451: Optimization of Normalized Prescription Isodose Selection for Stereotactic Radiation Therapy: Conventional Vs. Robotic Linac. (2012) (4)
Phase I feasibility and dose escalation multicenter trial of stereotactic body radiation therapy for liver metastases (2004) (4)
Stereotactic Body Radiation Therapy: Evaluation of Setup Accuracy and Targeting Methods for a New Couch Integrated Immobilization System (2008) (4)
Stereotactic Body Radiation Therapy for Renal Cell Carcinoma with Inferior Vena Cava Thrombus – Initial Experience Report and Literature Review (2019) (4)
Pre-treatment factors associated with detecting additional brain metastases at stereotactic radiosurgery (2016) (4)
A Matched-Pair Analysis of Sublobar Resection and Stereotactic Body Radiotherapy (SBRT) for Stage I NSCLC (2007) (4)
No Clinically Significant Changes in Pulmonary Function Following Stereotactic Body Radiation Therapy (SBRT) Among Medically Inoperable Patients With Early Stage Peripheral Non-small Cell Lung Cancer: An Analysis of RTOG 0236 (2012) (4)
Existence of a Dose-Length Effect in Spinal Nerves Receiving Single-Session Stereotactic Ablative Radiation Therapy. (2020) (4)
Stereotactic techniques for lung cancer treatment (2012) (3)
Prototype volumetric ultrasound tomography image guidance system for prone stereotactic partial breast irradiation: proof-of-concept (2018) (3)
Feasibility of BOLD Magnetic Resonance Imaging of Lung Tumors at 3 (2009) (3)
International Symposium on Ion Therapy: Planning the First Hospital-Based Heavy Ion Therapy Center in the United States. (2015) (3)
Stereotactic ablative radiotherapy in the framework of classical radiobiology: response to Drs. Brown, Diehn, and Loo. (2011) (3)
Brachial Plexus Tolerance to Single-Session Stereotactic Ablative Radiation Therapy (SAbR) in a Pig Model. (2021) (3)
An interdisciplinary consensus on the management of brain metastases in patients with renal cell carcinoma (2022) (3)
The effect of stereotactic ablative radiotherapy on time to change of systemic therapy in extra-cranial renal cell carcinoma metastases. (2016) (3)
Stereotactic Body Radiation Therapy for Early-Stage Non-small Cell Lung Carcinoma: Final Results of Phase II Study (2008) (3)
Long-Term Toxicity of Chemotherapy (2003) (3)
Predictors of High-Grade Rectal Toxicity Observed in a Phase 1/2 Trial of Stereotactic Body Radiation Therapy for Prostate Cancer (2013) (3)
Early Follow-Up of Multi-Institutional Trial of Phase I Dose Escalation Using Single Fraction Stereotactic Partial Breast Irradiation (S-PBI) for Early-Stage Breast Cancer. (2021) (3)
Accounting for respiratory motion in small serial structures during radiotherapy planning: proof of concept in virtual bronchoscopy-guided lung functional avoidance radiotherapy (2019) (3)
Considerations of target surface area and the risk of radiosurgical toxicity (2019) (3)
Phase 1 Dose Escalation Trial Using 5-Fraction Stereotactic Body Radiation Therapy For Partial Breast Irradiation (S-PBI) (2016) (3)
Motexafin gadolinium (MGd) combined with whole brain radiation therapy prolongs time to neurologic progression in non- small cell lung cancer (NSCLC) patients with brain metastases: Pooled analysis of two randomized phase III trials (2007) (3)
From Patchell to Brown: An Evidence-Based Evolution of the Role of Radiotherapy on the Management of Brain Metastases. (2016) (3)
Motexafin gadolinium prolongs time to neurologic progression in lung cancer patients with brain metastases: results of a randomized phase III trial (2002) (3)
Long term follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): A randomized phase II study comparing 2 stereotactic body radiation therapy schedules for medically inoperable patients with stage I peripheral non-small cell lung cancer (2019) (3)
Patterns of failure after induction chemotherapy followed by consolidative radiation therapy for children with central nervous system germinoma. (2003) (3)
A phase II trial of second-line erlotinib in combination with stereotactic body radiation therapy (SBRT) for patients with metastatic non-small cell lung cancer (NSCLC). (2013) (3)
Longitudinal Remote SBRT/SRS Training in Latin America: A Prospective Cohort Study. (2021) (3)
Margin-free Fractionated Stereotactic Radiotherapy for Pediatric Brain Tumors. (2020) (3)
Effectiveness of Abdominal Compression in Stereotactic Body Radiation Therapy (SBRT) Treatment of Lung and Liver: 4D CT Scan Analysis of Tumor and Organ Motion at Varying Levels of Abdominal Pressure (2007) (3)
A Phase I Dose Escalation Study of Stereotactic Body Radiation Therapy (SBRT) for Low- and Intermediate-risk Prostate Cancer (2009) (3)
Chapter 24 – Stereotactic Body Irradiation: Extracranial Tumors (2016) (2)
Contemporary Fractionation Trends within a Large United States Academic Radiation Oncology Department (2018) (2)
In reply to Zagar and Marks. (2012) (2)
Factors associated with progression and mortality among patients undergoing stereotactic radiosurgery for intracranial metastasis: results from a national real-world registry. (2022) (2)
Local Hypothermia as a Radioprotector of the Rectal Wall During Prostate Stereotactic Body Radiation Therapy. (2017) (2)
Phase I dose escalation trial using stereotactic body radiation therapy (SBRT) for partial breast irradiation (PBI). (2015) (2)
Reply to T. Sio et al. (2019) (2)
The Role of Gamma Knife Radiosurgery in the Management of Unresectable Gross Disease or Gross Residual Disease After Surgery in Ependymoma (2005) (2)
Assessing the Feasibility of Cone-Beam CT Simulation for Prophylaxis of Heterotopic Ossification Following Hip Surgery (2007) (2)
Volumetric Modulated Arc Therapy for Stereotactic Body Radiation Therapy of the Prostate (2011) (2)
Curing Metastatic Disease with Radiation Therapy: Myth or Reality?-Arguing for Reality. (2020) (2)
Safety and outcome of stereotactic body radiation therapy (SBRT) with rectal hydrogel spacer for prostate cancer. (2020) (2)
Superimposition of beams to vary shot size in gamma knife stereotactic radiosurgery (2002) (2)
A Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) Combined with Erlotinib for Patients with Recurrent Non-small Cell Lung Cancer (NSCLC) (2010) (2)
Long Term Results of a Phase I Dose-Escalation Trial and Subsequent Institutional Experience of Single-Fraction Stereotactic Radiation Therapy for Liver Metastases (2020) (2)
Optimal Imaging Follow-up Schedules after Stereotactic Ablative Radiotherapy for Early Non-Small-Cell Lung Cancer: Findings of an International Delphi Consensus Study (2017) (2)
Cost Effectiveness Analysis of Stereotactic Body Radiation Therapy (SBRT) versus Intensity Modulated Radiation Therapy (IMRT) for Low or Intermediate Risk Prostate Cancer: A Markov Model Decision Analysis (2011) (2)
From the guest editors: treatment of early-stage lung cancer. (2011) (2)
Intra-Fraction and Inter-Fraction Prostate Motion Associated With Stereotactic Body Radiation Therapy (SBRT) and Image Guided Radiation Therapy (IGRT) (2007) (2)
Prostate oncologic therapy while ensuring neurovascular conservation (POTEN-C): A phase II randomized controlled trial of stereotactic ablative body radiotherapy (SAbR) with or without neurovascular sparing for erectile function preservation in localized prostate cancer. (2020) (2)
On the value of carbon-ion therapy. (2016) (2)
Stereotactic Body Radiation Therapy (SBRT) Can Be Dosimetrically Equivalent to High-dose Brachytherapy as a Boost for Locally Advanced Cervical Cancer— A New Clinical Trial Concept (2012) (2)
Covering Gaps in Radiation Oncology Through Artificial Intelligence in Low-Resource Countries: A Survey-Based Analysis (2020) (1)
ESSFN The Mission (2009) (1)
Use of computed tomography for the fabrication of a custom brachytherapy carrier: a clinical report. (2003) (1)
Radiation to the Immune System May be an Important Risk Factor for Long-term Survival after SBRT in Early Stage Non-small Cell Lung Cancer: A Role of RT Plan Optimization (2018) (1)
162 : Stereotactic Body Radiotherapy for Early Stage Non-Small-Cell Lung Cancer in Patients With Very Poor Pulmonary Function (2006) (1)
2006 Biennial Meeting of the American Society for Stereotactic and Functional Neurosurgery. Boston, Mass., June 1–4, 2006 (2006) (1)
4D Cone Beam CT to Assess Daily Variation of Respiratory Motion after Abdominal Compression in Lung SBRT (2009) (1)
Phase 2 Trial of Stereotactic Ablative Radiotherapy for Patients with Primary Renal Cancer. (2023) (1)
Phase II trial of stereotactic ablative radiation (SAbR) for oligoprogressive kidney cancer. (2021) (1)
Impairment of neurocognitive function in brain metastases patients: baseline results from the phase III trial with motexafin gadolinium (2001) (1)
Stereotactic Radiotherapy of Lung Tumors (2005) (1)
Combining Serial and Parallel Functionality in Functional Lung Avoidance Radiation Therapy. (2022) (1)
Safety and Outcomes of Combining Immune Checkpoint Inhibitors with Radiation Therapy (2017) (1)
MONTE CARLO SIMULATION FOR LEKSELL GAMMA KNIFE ® RADIOSURGERY PLAN VERIFICATION (2003) (1)
Stereotactic Ablative Radiotherapy for Lung Cancer (2014) (1)
Analysis of extracranial stereotactic radiosurgery via equivalent uniform dose and tumor control probability: practical ramifications and translational implications (2002) (1)
MO‐D‐BRA‐03: Application of Hypofractionation in the Lung (2007) (1)
Dose Constraints for the Bladder and Urethra for Stereotactic Body Radiation Therapy to the Prostate (2017) (1)
Outcomes of stereotactic ablative radiotherapy for extra-cranial oligo-metastatic renal cell cancer. (2019) (1)
Benefit of Multimodality Image Acquisition in the Treatment Planning of Stereotactic Radiosurgery (SRS) of Arteriovenous Malformation (AVM) (2020) (1)
Impact of CDKN2A/B, MTAP, and TERT Genetic Alterations on Survival in IDH Wild Type Glioblastomas (2022) (1)
Phase 1 Dose Escalation Trial Using Stereotactic Body Radiation Therapy (SBRT) for Partial Breast Irradiation (PBI) (2014) (1)
Phase II Trial of Sipuleucel-T and Stereotactic Ablative Radiation therapy (SAbR) for Patients with Metastatic Castrate-Resistant Prostate Cancer (mCRPC) (2020) (1)
A Pilot Trial of Serial Ventilation and Perfusion Imaging in Patients with Medically Inoperable Stage I Non-small Cell Lung Cancer Treated with Stereotactic Body Radiotherapy (2010) (1)
SU-E-T-190: Design, Development, and Evaluation of a Modified, Anthropomorphic, Head, Quality Assurance Phantom for Use in Stereotactic Radiosurgery. (2011) (1)
Inhibition of Choroidal Neovascularization (CNV) by Adeno-Associated Virus (AAV) Mediated Expression of sFLT1 (2002) (1)
Ablative radiotherapy in oligometastatic pancreatic cancer to delay polyprogression, limit chemotherapy, and improve outcomes. (2022) (1)
A Novel Technique for Total Body Irradiation using Gantry Rotation and Beam Modulation (2008) (1)
In Regard to Valle et al. (2016) (1)
An Analysis of SBRT Localization Errors and Intrafraction Motion Using CBCT (2012) (1)
Initial Clinical Outcomes From a Prospective Phase 1 Trial of Hypofractionated Stereotactic Body Radiation Therapy for Early-Stage Glottic Larynx Cancer (2016) (1)
Stereotactic Body Radiation Therapy (SBRT) or Alternative Fractionation Schedules (2017) (1)
Stereotactic Ablative Radiation Therapy: Role in Treatment of Liver Metastases (2012) (1)
Biologically potent doses safely achieved in a multi-center trial of stereotactic body radiation therapy for liver metastases (2004) (1)
Safety Analysis From a Prospective Registry Study of Stereotactic Body Radiation Therapy for Aggressive Management of Late-Stage Disease (2016) (1)
A How-To Compendium for GammaPod Treatments, Clinical Workflow, and Clinical Program at an Early Adopting Institution. (2022) (1)
Management of isolated liver metastases (2014) (1)
XCYTRIN™ (motexafin gadolinium) and whole brain radiation for patients with brain metastases: Lead-in phase to randomized trial - final results (2000) (1)
Quality Metric to Assess Adequacy of Hydrogel Rectal Spacer Placement for Prostate Radiotherapy and Association of Metric Score With Dosimetric and Gastrointestinal Toxicity Outcomes. (2021) (1)
Neutrophilia and post-radiation thrombocytopenia predict for poor prognosis in radiation-treated glioma patients (2022) (1)
The Art of Radiation Therapy: The Necessary Risk of Radiation Necrosis for Durable Control of Brain Metastases. (2022) (1)
Preclinical Evaluation of Tumor Treating Fields Combined with Personalized Ultra-Fractionated Stereotactic Adaptive Radiotherapy (PULSAR) (2022) (1)
MA 13.08 Long Term Follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): a Randomized Phase II Study of 2 SBRT Schedules for Lung Cancer (2017) (1)
Predictors of survival for patients with brain metastases: results of a randomized phase III trial (2002) (1)
Development of a Phase I/II Clinical Trial Using Sterotactic Body Radiation Therapy (SBRT) for the Treatment of Localized Prostate Carcinoma (2006) (1)
Stereotactic Ablative Radiotherapy for Early Stage Lung Cancer (2011) (0)
Tissue assessment of therapeutic responses to neoadjuvant short course radiotherapy with and without anti-CD40 immunotherapy sotigalimab (sotiga) in rectal cancer. (2023) (0)
In Reply to Gerber et al. (2017) (0)
SU‐E‐T‐539: Maximum Energy of Helium and Carbon Ions Clinically Needed for Spine, Lung, Prostate and Pancreas Cancer (2015) (0)
Primary CNS Lymphoma: Comparison of Outcomes and the Use of Radiation Therapy in Patients Treated at a Public Safety Net Hospital vs. a Tertiary Academic Center. (2021) (0)
Imaging of pediatric cerebellar tumors (2012) (0)
SU-E-T-480: Radiobiological Dose Comparison of Single Fraction SRS, Multi-Fraction SRT and Multi-Stage SRS of Large Target Volumes Using the Linear-Quadratic Formula. (2014) (0)
Performance Deterioration of Deep Learning Models after Clinical Deployment: A Case Study with Auto-segmentation for Definitive Prostate Cancer Radiotherapy (2022) (0)
On the feasibility of improved target coverage without compromising organs at risk using online adaptive stereotactic partial breast irradiation (A‐SPBI) (2022) (0)
Abstract 5115: An orthotopic lung tumor model for image-guided microirradiation in rats (2015) (0)
External iliac lymph node coverage by lateral pelvic portals: Potential for marginal miss (1993) (0)
Stereotactic Ablative Radiotherapy for the Treatment of Pancreatic Metastases from Renal Cell Carcinoma (2022) (0)
Brain metastases regress isometrically following radiation, therapy allowing the use of 1D W.H.O. RECIST criteria for adequate response evaluation (2001) (0)
Modeling Radiosurgery Normal Tissue Dose: Target Surface Area Serves as the Best Single Pre-treatment Predictor (2019) (0)
Reducing PTV Margins with Daily Adaptive Radiotherapy to the Prostatic Fossa (2022) (0)
Developments in stereotactic ablative radiotherapy for the treatment of early-stage lung cancer (2013) (0)
Assessment of Breast Motion During Hypofractionated Robotic Radiation Therapy (2013) (0)
TH‐D‐M100J‐03: High‐Quality Four‐Dimensional CBCT Reconstruction with Virtual Projections (2007) (0)
Fractionated CyberKnife Radiotherapy for Sellar Lesions (2013) (0)
T Stage and Pretreatment Standardized Uptake Values Predict Tumor Recurrence With 5-Fraction SABR in Early-Stage Non-Small Cell Lung Cancer (2022) (0)
Accounting for Serial and Parallel Functionality of the Lung May Minimize Post-Radiotherapy Loss of Respiratory Function in Lung Cancer Patients. (2021) (0)
Dose-Response Relationship for Stereotactic Ablative Body Radiation Therapy Associated Airway Collapse (2015) (0)
Three-Year Cosmetic Outcomes of a Phase I Dose Escalation Trial of 5-Fraction Stereotactic Partial Breast Irradiation for Early Stage Breast Cancer (2020) (0)
Ablative Therapy: A Reasonable Approach. (2017) (0)
SU‐FF‐T‐427: The Significance of Higher Dose Rates for Stereotactic Body Radiation Therapy (2006) (0)
Extend Distance Treatment for Stereotactic Body Radiation Therapy of Lung Cancer (2009) (0)
Virtual Bronchoscopy-Guided Dose Response Modeling of Airways to Mitigate Radiation-Induced Airway Injury in Lung SAbR (2018) (0)
The impact of a mid-treatment MRI on defining GBM boost volumes (2002) (0)
Dosimetric and Motion Analysis of Margin-Intensive Radiation Delivery by Stereotactic Body Radiation Therapy for Operable Pancreatic Cancer (2011) (0)
Single-fraction Stereotactic Irradiation of Liver Metastases: Preliminary Results of a Phase I Trial (2012) (0)
In Reply to Dalwadi et al. (2020) (0)
The combination of radiation therapy and immunotherapy for genitourinary cancer treatment: rationale, current evidence, and prospects (2015) (0)
Phase 1 Study of Stereo-Ablative Radiation Therapy With the Use of SpaceOAR Hydrogel as Definitive Treatment of Prostate Cancer: Preliminary Experience (2013) (0)
TU-AB-303-03: CBCT-Based On-Site Simulation, Planning, and Delivery (OSPD) for Whole Brain Radiotherapy (2015) (0)
SU‐FF‐T‐433: Universal Survival Curve and SBRT Hypofractionation (2007) (0)
Dosimetric Verification Using Monte Carlo Calculations for Tissue Heterogeneity-corrected Conformal Treatment Plans for Lung Cancer Stereotactic Body Radiotherapy (2011) (0)
A Feasibility Study and Optimization of Dosimetric Objective with Heterogeneity Corrections for RTOG Studies with Hypo-fractionated Stereotactic Radiotherapy of Lung Cancers (2009) (0)
Addition of Iodinated Contrast to Rectal Hydrogel Spacer to Facilitate MRI-Independent Target Delineation and Treatment Planning for Prostate Cancer (2019) (0)
Use RTLS Assisted Electronic Checklist to Lifeguard Radiation Therapy Practice (2020) (0)
RADI-05. FRACTIONATED TREATMENT OF BRAIN METASTASES WITH GAMMA KNIFE ICON (2019) (0)
Lung Cancer Specialists’ Opinions on Treatments for Stage I Lung Cancer: A Multidisciplinary Survey (2016) (0)
In Reply to Hannoun-Levi et al. (2022) (0)
Toxicity and Efficacy Results From a Phase I Dose-Escalation Study of Single-Fraction Stereotactic Radiation Therapy for Liver Metastases (2014) (0)
Handbook of Advanced Cancer Care: Primary brain tumors (2003) (0)
Development of a Comprehensive Brachytherapy and Intraoperative Radiation Therapy Program at UT Southwestern (UTSW) (2016) (0)
Stereotactic Ablative Radiotherapy (SAbR) for Primary Renal Cell Carcinoma (2019) (0)
SU‐FF‐T‐571: A Dosimetric Comparison of Stereotactic Body Radiation Therapy Irradiation Techniques: CyberKnife Versus Conventional Linac‐Based Systems (2009) (0)
EP-1458: CBCT-Based On-site Simulation, Planning, and Delivery (OSPD) for whole brain radiotherapy (2016) (0)
Hypofractionated Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer-Does Size Matter?-Reply. (2022) (0)
Intraosseous High Dose Rate Brachytherapy (HDR) with Intramedullary Nailing for Long Bone Metastases – A Feasibility Study (2020) (0)
Pretreatment Factors Associated With Detecting Additional Brain Metastases at Stereotactic Radiosurgery (2015) (0)
SU-C-BRA-06: Automatic Brain Tumor Segmentation for Stereotactic Radiosurgery Applications. (2016) (0)
Consensus Quality Measures and Dose Constraints for Lung Cancer from the Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology (ASTRO) Expert Panel. (2023) (0)
Deformable Model and Four-Dimensional Reconstruction for Onboard CBCT (2007) (0)
A Deep Learning Based Brain Metastases Segmentation Web Platform for Stereotactic Radiosurgery. (2021) (0)
401: Efficacy of Ablative High dose Per Fraction Radiation for Implanted Human Renal Cell Cancer in a Nude Mouse Model (2006) (0)
Risk Factors for Fat Necrosis after Stereotactic Partial-Breast Irradiation (S-PBI) for Early-Stage Breast Cancer on a Phase I Clinical Trial (2019) (0)
Preliminary Evaluation of PTV Margins for Online Adaptive Radiotherapy of the Prostatic Fossa. (2022) (0)
Artificial Intelligence-Empowered Radiation Oncology Residency Education. (2023) (0)
SU-E-J-169: Process for QA of Normal Tissue Delineation and Reported Doses in Clinical Trials. (2014) (0)
SU-F-T-598: Robotic Radiosurgery System Versus Pencil Beam Scanning Proton Therapy for Definitive Intracranial Treatments. (2016) (0)
Combining Virtual Bronchoscopy with 4DCT-Based Ventilation Mapping to Preserve Serial- and Parallel-Functioning Lung Elements in Lung Stereotactic Ablative Radiotherapy (SABR) (2019) (0)
Hypofractionated 25Gy/5 Radiotherapy for Intracranial Meningiomas: Long-Term Follow-Up and Results (2019) (0)
Dose of Five Fraction Stereotactic Radiation to Thoracic Aorta Is Associated With Decreased Aortic Caliber: A Single-Institution Retrospective Study (2015) (0)
Primary central nervous system lymphoma: a real-world comparison of therapy access and outcomes by hospital setting. (2021) (0)
Early and Multiple PSA Bounces Can Occur Following High-Dose Prostate Stereotactic Body Radiation Therapy: Subset Analysis of a Phase 1/2 Trial (2014) (0)
Computational Analysis of the Dose Dependence of DNA Double Strand Break Repair Complex Formation (2008) (0)
Dose-Intensified Stereotactic Ablative Radiation for Localized Prostate Cancer (2022) (0)
Reply to "survival analysis for apparent diffusion coefficient measures in children with embryonal brain tumors," by Grech-Sollars et al. (2013) (0)
Novel unconventional radiotherapy techniques: Current status and future perspectives – Report from the 2nd international radiation oncology online seminar (2023) (0)
Patterns of Failure after 5 Fraction Stereotactic Ablative Radiation Therapy in Early Stage Non-Small Cell Lung Cancer (2018) (0)
EP-1289 Phase I dose escalation trial using single fraction Stereotactic PBI for early stage breast cancer (2019) (0)
PROSPECTIVE PHASE II PROTOCOL OF STEREOTACTIC BODY RADIOTHERAPY FOR MEDICALLY UNRESECTABLE PATIENTS WITH STAGE 1 NON-SMALL CELL LUNG CANCER (2005) (0)
Evaluation of fan-beam kilovoltage computed tomography image quality on a novel biological-guided radiotherapy platform (2023) (0)
Treatment of Multiply Recurrent Germ Cell Cancer (2003) (0)
SAbR for Primary Prostate Cancer (2019) (0)
MO-F-108-04: Inverse Planning for Multi-Stage Robotic Stereotactic Radiosurgery for Large Cerebral Arteriovenous Malformations. (2013) (0)
RO-24CONVENTIONAL FRACTIONATION WITH CYBERKNIFE® REDUCES VOLUME OF IRRADIATED TISSUE AND YIELDS EXCELLENT LOCAL CONTROL IN PEDIATRIC PRIMARY BRAIN TUMORS (2016) (0)
SU-C-BRA-07: Virtual Bronchoscopy-Guided IMRT Planning for Mapping and Avoiding Radiation Injury to the Airway Tree in Lung SAbR (2015) (0)
SU-F-T-651: Dosimetric Impact of Patient Setup Rotational Errors for Multi-Staged Large AVM Gammaknife Radiosurgery. (2016) (0)
Radiation to the Normal Lung May be an Important Risk Factor for Survival after Stereotactic Body Radiation Therapy in Non-Small Cell Lung Cancer (2017) (0)
A Phase I Dose Escalation Study of Stereotactic Body Radiation Therapy (SBRT) for Patients with Hepatic Metastases - Evidence of a Dose-response Relationship (2009) (0)
Abstract P6-05-55: Financial Toxicity Outcomes on a Phase I 5-fraction Partial Breast Irradiation Protocol for Early Stage Breast Cancer (2023) (0)
A Multi-Staged Treatment Planning Framework for Large-Volume Ventricular Tachycardia Stereotactic Ablation. (2021) (0)
Intraduodenal sarcoma recurrence of retroperitoneal origin: an unusual cause for a duodenal obstruction (2012) (0)
Predicting Distant Failure in Lung SBRT Using Clinical Parameters (2015) (0)
SU‐DD‐A4‐01: Phantom Study of Cone Beam Computed Tomography Setup Accuracy in Stereotactic Body Radiation Therapy for Lung Cancer Treatment (2010) (0)
Patterns Of Failure After Single Fraction Stereotactic Ablative Radiotherapy (SAbR) With A Simultaneous Integrated Boost (SIB) In The Treatment Of De Novo Spinal Metastases (2020) (0)
Unrecognized Germ Cell Tumor Syndrome (2003) (0)
Stereotactic Radiosurgery vs Conventional Radiotherapy for Localized Vertebral Metastases of the Spine: Phase 3 Results of NRG Oncology/RTOG 0631 Randomized Clinical Trial. (2023) (0)
Dose Escalation for Prostate Cancer Using Oligofractionated, Stereotactic Ablative Radiotherapy (2018) (0)
Therapy for Disseminated Disease (2003) (0)
SU-FF-T-569: A Study On the Dosimetric Accuracy of Lung Cancer Treatment Plan Using Average and Maximum Intensity Projection Images in Stereotactic Body Radiation Therapy (2009) (0)
MRI and 4D-CT Minimum Intensity Projection Volumes in Patients undergoing Stereotactic Body Radiation Therapy for Hepatic Lesions (2008) (0)
Study of Cone Beam Computed Tomography Setup Accuracy in Stereotactic Body Radiation Therapy for Lung Cancer Treatment-free Breathing vs. Controlled Breathing (2010) (0)
Prospective, multicenter evaluation of targeted radiofrequency ablation (t-RFA) and vertebral augmentation (VA) prior to or following radiation therapy (RT) to treat painful metastatic vertebral body tumors (STARRT Study): Interim analysis (2017) (0)
Treatment of Patients with “Poor-Risk” Disseminated Disease (2003) (0)
Preservation of Pulmonary Function Following Stereotactic Body Radiotherapy for Stage I Non-small Cell Lung Cance (2003) (0)
Benchmarking techniques for stereotactic body radiotherapy for early-stage glottic laryngeal cancer: LINAC-based non-coplanar VMAT vs. Cyberknife planning (2019) (0)
Multi-Institutional Trial of Phase I Dose Escalation Using Single Fraction Stereotactic Partial Breast Irradiation (S-PBI) for Early Stage Breast Cancer (2020) (0)
Dosimetric Analysis of 10 Fraction Stereotactic Robotic Radiation Therapy for Early-Stage Glottic Larynx Cancer (2015) (0)
Evaluation of Rectal Interfractional Dosimetric Variation using Balloon Immobilization during Volumetric Modulated Arc Therapy for Stereotactic Body Radiation Therapy of the Prostate (2011) (0)
Two-Dimensional Grayscale Ultrasound Artifacts (2016) (0)
411 INNATE: immunotherapy during neoadjuvant therapy for rectal cancer to elucidate local and systemic therapeutic responses (2021) (0)
SU‐GG‐J‐190: Use of CBCT in SBRT Treatments, UTSW Experience (2008) (0)
Introduction: Radiation Therapy in Oligometastatic Disease. (2021) (0)
RADI-36. FRAME-BASED VERSUS FRAMELESS GAMMA KNIFE RADIOSURGERY FOR BRAIN METASTASES (2019) (0)
(P084) Stereotactic Ablative Radiotherapy for Stage I Non-Small-Cell Lung Cancer Tumors Greater Than 5 cm (2017) (0)
Quality Metric to Assess Adequacy of Hydrogel Rectal Spacer Placement for Prostate Radiotherapy and Association of Metric Score with Rectal Toxicity Outcomes (2023) (0)
SU-G-JeP3-07: Real-Time Image Guided Radiation Therapy for Heterotopic Ossification in Patients After Hip Replacement. (2016) (0)
SU‐FF‐T‐395: Stereotactic Body Frame Apparatus (2006) (0)
Real-Time Online Adaptation for Accelerated Partial Breast Irradiation Significantly Improves Target Coverage without Compromising Organs at Risk (2022) (0)
Stereotactic Body Radiation Therapy for Prostate Cancer (2011) (0)
Virtual bronchoscopy-guided lung SAbR: dosimetric implications of using AAA versus Acuros XB to calculate dose in airways (2021) (0)
In Reply to Song et al. (2011) (0)
Discordance of patient- and physician-reported toxicities in two prospective trials of stereotactic body radiotherapy (SBRT) for localized prostate cancer. (2022) (0)
SU‐E‐T‐638: Optimization of Prescription Isodose Selection for Stereotactic Radiation Therapy: Conventional Linac vs. Cyberknife (2011) (0)
Adjuvant Radiation therapy with Immediate Interstitial Brachytherapy Following Surgical Excision for Pediatric Keloid (2020) (0)
Stereotactically-guided Permanent Iodine-125 Brachytherapy for Recurrent Pan-invasive Pituitary Macroadenomas (2011) (0)
A Support Tensor Machine Based Algorithm for Distant Failure Prediction in Lung SBRT (2017) (0)
Contents Vol. 85, 2007 (2007) (0)
Moody D. Wharam Jr, MD, FACR, FASTRO, July 22, 1941-August 10, 2018. (2019) (0)
Phase I Dose-Escalation Trial of Stereotactic Ablative Body Radiotherapy (SAbR) for Men with High-Risk Prostate Cancer (2020) (0)
What Neoadjuvant Radiation Volumes Should be Covered in Pancreas Cancer? An Analysis of Recurrence Patterns among Tumors with Arterial vs. Venous Involvement (2022) (0)
Mulling the Modalities. (2021) (0)
Evaluation of a Model-based Dose Calculation Algorithm (Acuros) for Intraosseous High Dose Rate Brachytherapy (HDR) With Intramedullary Nailing for Bone Metastases (2020) (0)
SU-E-T-431: Validation of Dose Escalation in Hypofractionated Hemi-Larynx Irradiation of Early-Stage True Vocal Cord Cancer Based On Anthropomorphic Phantom Measurements. (2013) (0)
Focal Salvage High Dose Rate (HDR) Brachytherapy after Neurovascular-Sparing Prostate Stereotactic Ablative Radiation Therapy (SAbR): A Pilot Dosimetric Study (2019) (0)
Volumetric Modulated Arc Therapy Based Total Body Irradiation – Five Year Clinical Experience (2020) (0)
Most troublesome quality of life concerns in patients with brain metastases: baseline results from the phase III trial with motexafin gadolinium (2001) (0)
In reply [9] (2007) (0)
Analysis of Survival Outcomes of Patients Treated with Stereotactic Radiosurgery for High Volume Brain Metastases (2022) (0)
Volumetric Modulated Arc Therapy Enabled Total Body Irradiation (VMAT-TBI) vs. Conventional TBI (cTBI): A Comparison of Treatment Outcomes and Toxicities (2022) (0)
A Phase II Trial of Stereotactic Ablative Radiotherapy for Patients with Primary Renal Cell Cancer (2020) (0)
Normal tissue Dose-constraints in Lung SBRT. (2004) (0)
Stereotactic Ablative Radiotherapy Prolongs Surveillance and Delays Initiation of Systemic Therapy in Patients with Renal Cancer Metastases (2017) (0)
Evaluating the Dosimetric Outcomes of Multistage Robotic Stereotactic Radiosurgery for Intracranial Arteriovenous Malformations (2012) (0)
A Single-Center Experience in Brachytherapy for Treatment-Refractory Nonsecreting Pituitary Adenomas (2020) (0)
Extracranial Renal Cell Carcinoma Treated With Stereotactic Ablative Body Radiation Therapy Leads to Excellent Lesional Control (2015) (0)
TH‐AB‐304‐05: Predicting Distant Failure in Lung SBRT Using Clinical Parameters (2015) (0)
Robotic patient positioning for radiation therapy delivery at varying source to target distances (2008) (0)
Phase II Trial of Sipuleucel-T and Stereotactic Ablative Body Radiation for Patients with Metastatic Castrate-Resistant Prostate Cancer (2022) (0)
Subject Index Vol. 85, 2007 (2007) (0)
Treatment Patterns, Outcomes and the Impact of Cellular Therapies in Secondary Central Nervous System Lymphoma (SCNSL): The UT Southwestern Experience (2022) (0)
Life-threatening hemoptysis in patients with metastatic kidney cancer. (2023) (0)
Socioeconomic and demographic determinants of radiation treatment and outcomes in glioblastoma patients (2022) (0)
RADI-33. DISTRIBUTED FRAMELESS GAMMA KNIFE RADIOSURGERY: A NEW TREATMENT PARADIGM FOR PATIENTS WITH BRAIN METASTASES (2019) (0)
OC-0668 MRI-only proton therapy treatment planning with synthetic CT images generated using deep learning (2019) (0)
Consensus Quality Measures and Dose Constraints for Breast Cancer from the Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology (ASTRO) Expert Panel. (2022) (0)
2063 : Endocrine Response After Gamma Knife Radiosurgery for Secretory Pituitary Adenoma (2006) (0)
Stereotactic body radiation therapy for oligometastases (Expert Review of Anticancer Therapy (2009) 9, 5, (621-635)) (2009) (0)
Comparison of Demographics, Treatment Patterns and Outcomes Among Primary Central Nervous System Lymphoma (PCNSL) Patients Treated at a Safety-Net Hospital Versus a Tertiary Academic Institution within the Same Healthcare System (2020) (0)
High-Dose Chemotherapy as Initial Salvage Therapy (2003) (0)
Stereotactic Ablative Radiation Therapy for Octogenarians With Lung Cancer: A Single Institution Retrospective Review (2013) (0)
SU‐GG‐T‐408: Computational Analysis of the Dose and Dose‐Rate Dependence of DNA Double‐Strand Break Repairs (2008) (0)
1520 poster COMPARATIVE DOSE-VOLUME ANALYSIS FOR FRACTIONATED RADIOTHERAPY OF CENTRAL BRAIN TUMORS IN PEDIATRIC PATIENTS USING CYBERKINFE, IMRT, AND BRAINLAB (2011) (0)
Extended distance non-isocentric treatment in stereotactic body radiation therapy (SBRT) for lung cancer (2014) (0)
Identification of occult brain metastases amenable to stereotactic radiosurgery by motexafin gadolinium (MGd) based treatment planning MRI: Results of a phase II trial of MGd and whole brain radiotherapy (WBRT) with stereotactic radiosurgery (SRS) (2007) (0)
Intramedullary brachytherapy for the treatment of long bone metastatic disease: A case report (2021) (0)
SU-F-T-650: The Comparison of Robotic Partial Breast Stereotactic Irradiation Using MLC Vs. Iris Cone. (2016) (0)
Time Dependence of Coverage of the Prostatic Fossa: Implications for Daily Adaptive Radiotherapy (2022) (0)
Prospective Safety and Feasibility trial of Nivolumab and Stereotactic Ablative Radiation Therapy (SAbR) for Metastatic Clear Cell Renal Cell Carcinoma (mRCC) (2020) (0)
Frameless Stereotactic Placement of Brachytherapy Seeds within a Pituitary Adenoma via Endoscopic, Endonasal Approach: A Technical Note (2020) (0)
Immune Correlates of Abscopal Response in a Lead-in Phase II Trial of Neoadjuvant Stereotactic Ablative Radiotherapy (SABR) for Renal Cell Carcinoma Inferior Vena Cava Tumor Thrombus (2019) (0)
Phase 2 Trial of High-Dose Interleukin-2 (IL-2) and Stereotactic Ablative Radiation Therapy (SABR) for Metastatic Clear Cell Renal Cell Carcinoma (mRCC)—Interim Analysis of i-SAbR IL-2 Trial (2016) (0)
2183 Fractionated radiotherapy in the treatment of neuroblastoma (1996) (0)
Multistage Stereotactic Radiosurgery for Large Intracranial Arteriovenous Malformations: Focused Cobalt-60 Radiosurgery Versus Robotic Radiosurgery (2014) (0)
Survival a nd N eurologic O utcomes i n a R andomized T rial o f Motexafin G adolinium a nd W hole-Brain R adiation T herapy i n Brain M etastases (2003) (0)
SU‐GG‐T‐543: The Effect of Respiratory Motion on the Dose Distribution of Free‐Breathing Stereotactic Body Radiation Therapy for Spinal Tumors (2010) (0)
TH-EF-BRB-11: Volumetric Modulated Arc Therapy for Total Body Irradiation. (2016) (0)
Phase II trial of clinical activity and safety of ceritinib combined with stereotactic ablative radiotherapy (SABR) in lung adenocarcinoma patients. (2020) (0)
Tumor alignment between 4DCT and 4D cone beam CT for Irregular respiratory patient - A phantom study (2009) (0)
Abstract 3272: Tumor treating fields combined with the PULSAR paradigm for radiotherapy and an immune checkpoint inhibitor enhances antitumor efficacy in vivo (2023) (0)
SU-E-T-251: Novel Multi-Stage Stereotactic Radiosurgery Technique for Large Cerebral Arteriovenous Malformations Using the Gammaknife System. (2014) (0)
SU-E-T-540: Volumetric Modulated Total Body Irradiation Using a Rotational Lazy Susan-Like Immobilization System. (2014) (0)
Ensemble learning for glioma patients overall survival prediction using pre-operative MRIs (2022) (0)
Mandibular Implant-retained Overdentures An Eight-year Follow-up to a Randomized Clinical Trial of Participant Satisfaction with Three Types of (0)
Dosimetric and Deformation Effects of Image Guided Interventions During Stereotactic Body Radiation Therapy of the Prostate Using an Endorectal Balloon (2012) (0)
Comprehensive target geometric errors and margin assessment in stereotactic partial breast irradiation (2017) (0)
SU-DD-A1-01: Fast Dose Calculation for Pigmented Villonodular Synovitis Treated with P-32 Radiocolloids (2007) (0)
Stereotactic ablative body radiation therapy for tumors in the lung in octogenarians: a retrospective single institution study (2014) (0)
Validation and Comparison of Dosimetry for Small Lung Targets in Stereotactic Body Radiation Therapy (SBRT) (2008) (0)
Improved survival rates in kidney cancer patients with brain metastases treated with modern multidisciplinary approaches. (2018) (0)
Cost-Effectiveness Analysis of Stereotactic Ablative Radiation Therapy Versus Single-Fraction External Beam Radiation in Painful Vertebral Body Metastases (2013) (0)
Phase I feasibility and dose escalation multicenter trial of stereotactic body radiation therapy for liver metastases. (2004) (0)
SU-E-T-429: Feasibility Study On Three-Dimensional GRID Therapy in Conventional Linacs (2015) (0)
Treatment of Good-Risk Disseminated Germ Cell Tumors (2003) (0)
Relative Motion of Implanted Prostate Fiducials During Stereotactic Body Radiation Therapy (2007) (0)
Comparison of Superficial Radiation and HDR Brachytherapy Following Surgical Excision for Keloid (2020) (0)
SU-GG-J-56: Can Four Dimensional Cone Beam Computed Tomography (4DCBCT) Improve the Patient Setup for Stereotactic Body Radiation Therapy (2010) (0)
MO-FG-BRA-08: Swarm Intelligence-Based Personalized Respiratory Gating in Lung SAbR. (2016) (0)
SU-E-T-812: Volumetric Modulated Arc Therapy-Total Body Irradiation (VMAT-TBI) V.s. Conventional Extended SSD-TBI (cTBI): A Dosimetric Comparisom (2015) (0)
In Reply to Mendenhall et al. (2020) (0)
Life-threatening hemoptysis in patients with kidney cancer chest metastases (2023) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Robert D. Timmerman?

Robert D. Timmerman is affiliated with the following schools:

Indiana University
University of Minnesota
University of Texas Southwestern Medical Center

Robert D. Timmerman's Academic­Influence.com Rankings

Why Is Robert D. Timmerman Influential?

Robert D. Timmerman's Published Works

Published Works

What Schools Are Affiliated With Robert D. Timmerman?

Robert D. Timmerman's AcademicInfluence.com Rankings